Better Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Better Therapeutics

14/11/2022 22:02

* Better Therapeutics Inc  BTTX.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 48 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Better Therapeutics Inc's reported EPS for the quarter was
a
loss of 48 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Better Therapeutics Inc shares had fallen by 16.5% this
quarter and lost 68.4% so far this year.
    * The company reported a quarterly loss of $11.41 million.
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.48          -0.48          Met
 Jun. 30 2022      -0.45          -0.42          Beat
 Mar. 31 2022      -0.38          -0.41          Missed
 Dec. 31 2021      -0.46          -0.71          Missed